🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare improvement percentage of urinary a...
Status
Completed
Location
Koshiro Fukiyama
Start Date
2006-07
Trial ID
NCT00460213
Treatments Being Tested
The primary objective of the study is to determine whether, in patients wit...
Status
Completed
Location
Cedars-Sinai Heart Institute
Start Date
2017-03-02
Trial ID
NCT02816736
Treatments Being Tested
To determine whether the combination of nifedipine GITS and valsartan is mo...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01071122
Treatments Being Tested
To evaluate the efficacy and safety of aliskiren alone and in combination w...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-06
Trial ID
NCT00219180
Treatments Being Tested
The DART-HA study is a single-center, open label, trial intended to evaluat...
Status
Recruiting
Location
Heart Center Research, LLC
Start Date
2021-07-08
Trial ID
NCT06218199
Treatments Being Tested
The purpose of this study was to evaluate the effect of LCZ696 compared to ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-18
Trial ID
NCT01920711
To assess the pharmacokinetic characteristics of valsartan and S-amlodipine...
Status
Completed
Location
Metro Hospital
Start Date
2013-03
Trial ID
NCT01819779
Treatments Being Tested
To evaluate efficacy and safety of valsartan 160mg in Chinese hypertensive ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01541189
Treatments Being Tested
The purpose of this study is to assess the potential of using valsartan/HCT...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-11
Trial ID
NCT00273299
Treatments Being Tested
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonep...
Status
Unknown
Location
Peing Union Medical College Hospital
Start Date
2016-06
Trial ID
NCT02765594
Treatments Being Tested